Last10K.com

Advaxis, Inc. (ADXS) SEC Filing 8-K Material Event for the period ending Friday, October 26, 2018

SEC Filings

ADXS Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

ADXS Annual Reports

ADXS Quarterly Reports

ADXS Corporate News

ADXS Merger Prospectus

ADXS Registration of Securities

Advaxis, Inc.

HISTORY TOOLS
CIK: 1100397 Ticker: ADXS

View differences made from one to another to evaluate Advaxis, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Advaxis, Inc..

Continue

Assess how Advaxis, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Advaxis, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: ADXS
CIK: 1100397
Form Type: 8-K Corporate News
Accession Number: 0001493152-18-014888
Submitted to the SEC: Fri Oct 26 2018 4:00:20 PM EST
Accepted by the SEC: Fri Oct 26 2018
Period: Friday, October 26, 2018
Industry: Pharmaceutical Preparations
Events:
  1. Listing Status

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/adxs/0001493152-18-014888.htm